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Methods: A systematic literature search was conducted in four databases yielding 9840 records.
Relevant studies were identified and selected using predefined inclusion and exclusion criteria and
then coded and classified according to assessment type. This was completed by two independent re-
searchers, with a third consulted when discrepancies arose. The review collates diagnostic instru-
ments and presents strengths and weaknesses.
Results: Overall 47 studies met the search criteria, and 43 instruments were extracted from the
selected studies. Of which, 10 instruments were classified as test batteries, 23 were classified as direct
cognitive tests, and the remaining 10 were informant reports.
Discussion: This review can recommend that cognitive test batteries can offer the most practical and
efficient method for dementia diagnosis in individuals with ID.
 2016 Published by Elsevier Inc. on behalf of the Alzheimer’s Association. This is an open access
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An intellectual disability (ID), similar to the UK specific
term learning disability, onsets during the developmental
period and is characterized by impairments of general
mental abilities that impact adaptive functioning in three
main domains: conceptual, social, and practical (American
Psychological Association, 2013). [1] Various studies dis-
cussed throughout this review refer specifically to Down
syndrome (DS). This is the most common genetic ID disor-
der seen in clinical practice. DS is caused 94% of the time by
nondisjunction of chromosome 21 and 3%–5% of the time
by translocation. The IQ of people with DS falls within the
mild to moderately severe ID spectrum [2].
The life expectancy of individuals with ID is increasing
due to improvements in medicine and living circumstancesthor.
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licenses/by-nc-nd/4.0/).[3,4]. Individuals with mild ID are even experiencing life
spans equal to those of the general population [5]. Adults
with ID are subsequently in a position where age-related ill-
nesses are becoming a greater concern. The most notable of
these illnesses is dementia, for which an individual’s age is
the strongest risk factor (e.g., Daviglus et al [6]). Dementia
of the Alzheimer’s type is a cognitive impairment that gradu-
ally onsets, is progressive, and leads to interference with so-
cial and occupational functioning [7]. Dementia can be
caused by a variety of underlying pathology. For example,
Alzheimer’s disease (AD) [8] consists of amyloid plaques
and neurofibrillary tangles in the cerebral cortex, temporal
lobe cortex, and hippocampus, among other brain areas [9].
Furthermore, individuals with ID often experience onset
of aging characteristics earlier than in the general population
[10], and this is reflected in age of dementia diagnosis. Onset
of dementia usually occurs among older adults over the age
of 65 years; however, in individuals with DS, onset is usually
around the early 50s [11].ation. This is an open access article under the CC BY-NC-ND license (http://
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lence estimates of dementia in ID populations with and
without DS when compared to the general population.
Dementia has been shown to be common in older adults
with ID but prevalence rates reported differ according to
the diagnostic criteria applied [12]. It was found that
diagnoses of dementia are substantially higher than in the
general population, for people who have ID but do not
have DS [13]. 21.6% of participants were diagnosed with
dementia, compared to 5.7% that was expected in a non-
ID group with this age structure. This was further supported
by Strydom et al. [14] who highlighted the incidence rate of
dementia in ID to be five times higher than that of older
adults in the general population. Other studies have shown
prevalence rates to only be comparable or higher than in
the general population (e.g., Strydom et al. [15]). Opposing
studies have shown risk of dementia to be equivalent to or
lower than in the general population (e.g., Zigman et al.
[16]). The variety in prevalence estimates further highlights
the divergence in the understanding and application of
dementia diagnostics for individuals with ID.
Stronger evidence has been established regarding de-
mentia rates in individuals with ID and DS. Incidence of
early-onset dementia of the Alzheimer’s type has been
shown to be higher than in the general population (e.g.,
Bush et al. [17]). Genetic findings have suggested that
owing to the complex etiology of DS and the triplication
of the amyloid precursor protein gene on chromosome 21,
DS could be considered a model of early-onset dementia
[18]. Almost all adults with DS over the age of 35–40 years
show neuropathologic changes characteristic of AD [19],
including senile plaques and neurofibrillary tangles.
Although this does not necessarily reflect a clinical diag-
nosis, genetic evidence has merely begun to highlight sim-
ilarities between the neuropathology of the two conditions.
Unsurprisingly however, individuals with DS in many cases
have been shown to be at higher risk of developing Alz-
heimer’s disease than the general population (e.g.,
Nieuwenhuis-Mark [20]).
There is a need for further clarification of the difference in
prevalence rates between the three populations, individuals
from the general population with no pre-existing impair-
ment, individuals with ID but without DS and individuals
with ID and DS. Regardless of comparisons to the general
population, evidence does show that the prevalence rates
of dementia in ID increase dramatically between the ages
of 40 and 60 years [21]. Therefore, dementia diagnostic as-
sessments should be targeted at this age group or before.
Diagnosing dementia can be an incredibly difficult and
complicated process. This is remarkably more complex in
individuals with ID, as dementia and related pathology is
manifested in areas of functioning that are, more than likely,
already impaired by the intellectual disability [22]; thus
leading to inherent difficulties in assessing cognitive func-
tioning to aid with dementia diagnostics in people with ID
[21]. There is no agreement in the literature or in practiceon how dementia diagnosis should be informed in ID popu-
lations (e.g., Moran et al. [23]).
Assessments within the general population that build up a
picture to aid the clinician when diagnosing dementia in-
volves direct cognitive tests that indicate progressive cogni-
tive decline in areas such as short-term and long-term
memory, orientation, communication and mood, among
others. But these tests are frequently not appropriate for indi-
viduals with ID as they often require abilities that individuals
with ID may find more difficult due to their pre-existing
impairment. The tests are not often developed for use in ID
populations, and therefore, they do not reliably screen for de-
mentia in this group [24]. Moreover, there are no normed data
for this population, and thus, results cannot be interpreted
meaningfully [23]. Consequently, floor effects are often
observed on the chosen test and problems of accuracy in diag-
nosis ensue. There are three potential assessment methods
that practitioners can apply to help inform diagnosis. These
include a single test that directly assesses the individual’s
cognitive functioning, a test battery which comprises of mul-
tiple tests that assess a range of cognitive functions and lastly,
informant reports which are completed by a carer or close
relative who can report on the individual’s functioning.
This review aims to collate existing instruments used in
the diagnosis of dementia in individuals with ID. The instru-
ments will then be coded according to whether they are (1) a
direct cognitive test, (2) informant report, or (3) a test bat-
tery. The review will then discuss the benefits of each type
of test. This review shall build on previous reviews by pre-
senting an up to date overview of the instruments available,
as well as discussing instruments that have been proposed
for diagnostics in adults with ID but have yet to be estab-
lished as such. This could include instruments that are de-
signed for use in the general population, in the
intellectually disabled populations or in people who have
already been diagnosed with dementia. This review will
therefore help clinicians to extend their knowledge of the po-
tential cognitive assessments available as well as discuss
non-cognitive assessments being used and give recommen-
dations based on previous literature.
2. Methods
2.1. Literature search
A systematic literature search was conducted in four data-
bases: PubMed, Science Direct, Google Scholar and PsycInfo.
These databases were selected due to the depth and breadth
that they offer in literature searching and their relevance to
the reviewed topic. The search string included various terms
for (1) the measure of interest (e.g., Alzheimer’s disease, De-
mentia, Dementia of Alzheimer’s type) and (2) the output of
interest (e.g., diagnosis, assessment, instrument, screening
tool). The searchwas performed once for the (3) specified pop-
ulation (e.g., intellectual disability, learning disability, mental
retardation) and again for (4) Down syndrome, due to the well
documented increased risk of dementia of Alzheimer’s type in
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of the search strategy. References of included studieswere also
hand-searched, to include further relevant studies. Both En-
glish and non-English publicationswere sought after. However
due to searches being conducted in English only, publications
that had been originally written in English or translated into
English were able to be included.
Relevant studies were identified and selected using the
following inclusion criteria. Identified studies should be
suitable dementia assessments for individuals with ID;
this included informant reports, independent direct cogni-
tive tests, or test batteries. Test batteries were included
with both cognitive assessment and noncognitive assess-
ment reported by an informant. Direct cognitive tests that
are not yet used for dementia assessment but test a specific
aspect of cognitive functioning like memory, intelligence,
or orientation in an intellectually disabled population
were included. Participants in selected studies included
participants with ID that were classified as mild, moderate,
severe, with or without the presence of DS. Included studies
compared individuals with ID to individuals with ID who
had already been diagnosed with dementia. Reviews, guid-
ance documents, and dissertation projects were included
when they pertained to the topic to consider and build on
previous findings. These publications included discussion
of dementia diagnostics in ID, instruments used for cogni-
tive assessment, informant reporting for the purpose of de-
mentia assessment, and guidance documents regarding
dementia diagnostics or assessment in individuals with ID.
Studies were excluded if the instruments presented were
not suitable for use in ID or DS populations. The instrument
did not need to have been used for the purpose of diagnosis as
of yet, but if it had been shown to be tolerated well by partic-
ipants with ID and had been suggested for use in dementia
assessment, then it was considered in this review. Diagnostic
checklists and criteria were excluded as this review aimed to
assess instruments that assess an individual with ID’s
functioning, either via an informant or directly, to aid the
practitioner to complete checklists and criteria for dementia
diagnosis. Checklists, although helpful whenmaking the final
decision regarding diagnosis, require heavy input from
trained clinicians. This review sought to identify assessment
methods that can be completed before input from the clinician
as this will give the opportunity for diagnosis to bemademoreTable 1
Search string logic
Search Terms Output Measure
Synonyms Informant report, direct test, test battery,
diagnosis, diagnostic, screening,
assessment, tool, questionnaire, Scale
Dementia
Demen
Combined and
Truncated
Inform* OR Informant Report* OR diagnos*
OR screen OR screening* OR instrument*
OR tool* OR Assess* OR questionnaire
OR Scale*
Dement*efficiently. Likewise, medical tests or studies focusing on
biological or genetic markers were also excluded, due to their
differential emphasis in the diagnostic process. Studies
looking at interventions and treatments were also excluded
due to lack of relevance to the diagnostic process.
2.2. Extraction of information and coding of instruments
Instruments were extracted from included studies and
coded according to whether they were (1) an independent
direct cognitive test completed by the individual, (2) an infor-
mant report completed by a carer or consultee on behalf of the
individual or (3) a test battery consisting of multiple tests. In-
strumentswere then put into the table that correspondswith the
given code. Therefore if an instrument was coded as a direct
cognitive test then it was placed into Table 2. Informant reports
were added to Table 3, and finally Test batteries were placed
into Table 4. Test batteries contain many different independent
direct cognitive tests and informant reports, if the instrument
was included in a battery it was described in Table 4, although
it may be applicable to Table 2 or 3, this is to avoid repetition,
so when considering which instrument to use do bear in mind
that individual tests contained within test batteries are also
available (see Table 4 for references). Instruments were further
coded to highlight the level of ID and whether DS was present
during the specified study. Tables therefore are displayed with
non-DS participants denoted first, starting with mild ID, then
moderate, and finally severe. After this, studies that compared
ID participants without DS to participants with equivalent
level of ID andDS aswell. Finally, the tables displayed studies
conducted with participants who have ID and DS. Selection
and coding of studies were completed by two independent re-
searchers (JEK, SS), with a third independent researcher con-
sulted when discrepancies arose (RD).3. Results
3.1. Results of the literature search
The literature searches conducted in all four databases
yielded a total of 9840 studies. After excluding duplicates,
screening titles and abstracts, 74 studies remained. These
were assessed in full text, a further 34 studies were excluded
at this point for not meeting the inclusion criteria. Thirty-six
studies remained, and their references were hand searchedPopulation
, Alzheimer’s disease,
tia of Alzheimer’s type
Intellectual Disability, Learning Disability,
Mental Retardation, Developmental
Disability, Down Syndrome, Downs
Syndrome.
OR Alzheimer* ((Intellectual* OR mental* OR learning OR
developmental*) AND (disab* OR
retard*)) OR (Down* AND syndrom*)
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overview of the whole search and the results is shown in
Fig. 1. In total, 48 studies met the search criteria.
A total of 44 instruments were found in the 47 included
studies. There were 33 instruments to be completed by the
individual and 11 to be completed by the carer or consultee.
Of the 33 tests completed by the individual, 10 test batteries
were identified, and 23 independent direct tests were identi-
fied. In the following sections, the instruments extracted are
described in further detail.3.2. Direct cognitive tests
During the literature search, 23 instruments coded as direct
cognitive test batteries were identified; these are listed in
Table 2. They each assess an aspect of cognitive functioning
hypothesized to be associated with dementia, and therefore
useful to assesswhen consideringmaking a diagnosis.Various
aspects of memory were the most frequently tested cognitive
function. Memory domains included visual recognition, vi-
sual spatial, explicit, recall, and cued recall. Numerous tests
sought to take a snapshot of overall cognitive functioning
and mental status. Alternatively individual cognitive domains
assessed included learning, various aspects of language, ob-
ject recognition, executive function, and intelligence, among
others.Many tests still incurred floor effects when participants
were classed as having severe ID, reducing the tests potential
for practical usage (e.g., PCFT [42]; MMSE [48]; CAMCOG
[50]). The comments column in Table 2 denotes when a test
has encountered this problem.3.3. Informant reports
The informant reports highlighted by the studies in this
review are detailed in Table 3. A total of 11 informant re-
ports were reviewed. The informant reports nearly all as-
sessed either behavior, dementia status, or daily
functioning. These are noncognitive symptoms of demen-
tia that indirectly indicate changes in cognitive func-
tioning. When the participant is classed as having severe
ID, these methods are more favored, as they do not
require the individual to complete any tests that they
may potentially find distressing. All informant reports in
Table 3 were shown to be effective during the dementia
diagnostic procedure, except for the Activities of Daily
Living Questionnaire (ADL [54]), which was shown to
not be effective in this population [55]. The Dementia
Questionnaire for Mentally Retarded people (DMR
[56]), which has been renamed at the Dementia Question-
naire for people with Learning Disabilities (DLD [57])
and Adaptive Behaviour Scale (ABS [43]) was high-
lighted to be most effective when used together, as they
can cover a wide range of factors affected by dementia.
This suggests that both adaptive behavior and general
cognitive functioning that are assessed with these two
scales are implicated in dementia diagnosis.3.4. Test batteries
There were 10 test batteries identified in the literature
search; which are listed in Table 4. Of these 10 batteries,
four were designed for individuals with ID and five for indi-
viduals with Down syndrome. The remaining battery was
designed for individuals in the general population who are
already severely demented, rather than for use as an assess-
ment battery. Eight of the batteries contained sections for
informant reports as well, whereas two of the batteries chose
to focus on just the participant’s cognitive abilities. The test
batteries varied in length from 20 minutes (severe impair-
ment battery), up to 4 hours (Das Naglieri Cognitive Assess-
ment System).3.5. Other studies assessed
Table 5 shows the other studies reviewed. Although these
studies did not present specific instruments, they discussed
instruments available and presented their recommendations
for diagnosis of dementia for people with ID and Down syn-
drome. Overall seven other studies were assessed, of which
five were classed as literature reviews and two were classed
as recommendation or advise documents, issued with the
intention of informing practitioners of which route to take
when diagnosing dementia in people with ID. All the docu-
ments agreed that a consensus should be reached to further
research and benefit clinical practice. Many of the studies
also highlighted how crucial longitudinal use of the chosen
screening instrument is to accurately inform diagnosis
[113] further argues for individually tailored assessment
techniques to be employed, as many of the studies noted
that the variability in cognition of individuals with ID makes
it almost impossible to recommend one set instrument.
Therefore selecting appropriate tests for the individual is
key. Some studies also note the use of a multidisciplinary
approach to most successfully inform diagnosis. This re-
quires obtaining knowledge of the patient’s history and mak-
ing observations of not only their cognitive functioning, but
also emotional, motivational and daily functioning.4. Discussion
4.1. Summary
In this review, instruments that are used in the assessment
of dementia in individuals with intellectual disabilities (IDs)
were systematically collected and described. This review
also presents information regarding the available instru-
ments in a more accessible and condensed form for clini-
cians to use to inform decisions regarding dementia
diagnostics for individuals with ID. Furthermore, strengths
and weaknesses of each type of instrument were discussed.
The three categories of diagnostic instruments presented are
direct cognitive tests, informant reports, and test batteries. Pre-
vious reviews agree that consensus needs to be reached to
advance assessment of dementia in ID (e.g., Zeilinger et al.
Table 2
Direct cognitive tests
Author (Year)
Country and setting
(clinical or applied) Test name Ability tested Ppts Type of ID Groups Outcome (what was sig?)., Comments
McDaniel
(2000) [25]
United States—
Applied setting
(quiet room
in their unit)
Dementia Rating
Scale (DRS) [26]
General cognitive
ability
84 ppts
Aged:
14–60 years
Mild ID
(n 5 32)
Moderate ID
(n 5 42)
Severe ID
(n 5 10)
1 5 Mild
2 5 Moderate
3 5 Severe
1. 2 (sig) on Total Score and
all subtests except
Construction
2 . 3 (sig) on all measures.
DRS can provide info about
the cognitive strengths
and weaknesses of
individuals with ID.
DRS can be administered to
a wide range of
individuals with ID.
Pyo et al.
(2010) [27]
United States—
Applied Setting
(separate room
with a family or
staff member
present to make
ppts feel more
comfortable)
The revised Picture
Recognition
Memory Test
(r-PRMT) [28]
Visual recognition
memory
59 ppts (26
cases, 33
controls)
Age: 401
Moderate
to severe
1 5 DAT cases
with DS (n 5 15)
2 5 DAT cases
without DS
(n 5 11)
3 5 Controls with
DS (n 5 9)
4 5 Controls
without DS
(n 5 24)
Controls . Cases on r-PRMT
Controls with non-DS
etiologies scored much
lower with a wider score
spread, resulting in
significant overlap with the
score distribution of DAT
cases.
Effect sizes indicated that ppts
with DS were 5.35 for r-
PRMT immediate and 4.44
for r-PRMT delayed which
were significantly larger
compared to non-DS ppts
who showed effect sizes of
0.73 and 1.02, respectively.
r-PRMT may be effective at
identifying DAT among
moderate to severe from
DS, however high false
positive rate.
The Modified
Objective Memory
Test (OMT)
Recall memory Cases5 controls on OMT (no
sig difference)
Test for severe
impairment (TSI) [29]
Mental status as a
whole, including
immediate
memory recall
and delayed
recall.
Cases 5 controls on TSI (no
sig difference)
The Neuropsychology
(NEPSY)
Comprehension of
Instructions [31]
Language
comprehension
Cases 5 controls on The
NEPSY (no sig difference)
Shultz et al.
(2004) [30]
United States—
Applied setting
(designated
rooms at ppts’
group homes
or workshops)
The Shultz Mental
Status Exam
Overall mental
Status
38 ppts
aged: 45–74
years
ID without
DS (32%)
and ID with
DS (68%)
Cases 5 Dementia
Controls 5 Non
dementia
Both performance tasks
discriminated between
groups. The performance
tasks were related to dementia
and IQ, but not age or sex.
Both the Shultz Mental
Status Exam and the paired
associate learning task were
able to detect cases versus
controls and therefore could
be informative when
diagnosing dementia in ID.
Paired Associate
Learning Task
(modified
from [32])
Visual Spatial
Explicit
Memory
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Krinsky-
McHale
et al.
(2002) [33]
United States—
Potentially a
clinical setting
but this is not
specified.
Selective Reminding
Test (SRT) [34]
Modified for
use in this
population [35]
Explicit Memory 155 ppts Down
Syndrome vs
individuals
with ID but
no DS.
Equivalent
level of ID
between
groups.
Cases 1 5 DS
with DAT
Controls 1 5 S
without DAT
Cases 2 5 ID
without DS
with DAT
Controls 2 5 ID
without DS
without DAT
Cases 1 , controls 1 and
cases 2 , controls 2 on
long-term storage and
retrieval processing
abilities
These declines preceded
other DAT symptoms, in
most cases by more than
1 year & sometimes up to
3 years. Results confirm
SRT can detect affected
memory processes during
early dementia in adults
with DS.
Das et al.
(1995) [36]
Canada and
United States
—Applied
setting (quiet
rooms located
in a workshop,
group or
independent
living setting)
Dementia Rating
Scale (DRS) [26]
General cognitive
ability
63 ppts
Age: 40–49
years or
50–62 years
Down
syndrome vs
individuals
with ID but
no DS.
Equivalent
level of ID
between
groups.
Younger cases 5
DS aged 40–49
years
Younger controls
5 non-DS aged
40–49 years
Older cases 5 DS
aged 50–62 years
Older controls 5
non-DS aged
50–62 years
Older cases , younger cases,
younger controls, older
controls
Older DS individuals
performed most poorly on
the tasks involving planning
and attention.
DRS indicates good clinical
utility. PPVT-r also
discriminated effectively.
Matrix was found to be too
difficult for individuals
with moderate to severe
ID to complete.
Peabody Picture Vocab
Test—revised [37]
Receptive
vocabulary
Matrix—Analysis
Test—expanded
form [38]
Nonverbal
measure of
intelligence
Nelson et al.
(2007) [39]
United States—
Clinical
Setting
Simple visual
discrimination
Visual
discrimination
learning
19 ppts
Age: 24–55
years
Mean 5 40
Down
syndrome
Results demonstrated good
reliability and validity of
select tests.
Reversal learning Executive function Reversal and landmark 0:
Sensitivity 71.43 and
specificity 72.73
Sensitivity and specificity
not given for tests
individually.
Delayed non-match
to sample
Object recognition Delayed non-match to sample
and landmark 4:
sensitivity, 72.73; specificity
27.27
Landmark stimulus—
response task
Spatial learning
and memory
Landmark 4: sensitivity 75;
specificity 60
McCarron
et al (2014)
[40]
Ireland & United
States—Clinical
Setting (Memory
clinic)
Downs Syndrome
Mental Status
Exam (DMSE) [41]
Overall mental
status
77 ppts
Aged:
351 years
Down
syndrome
Cases 5 dementia
Controls 5
nondementia
Average age of
diagnosis 5 55.41
(SD 5 7.14)
Median survival 5 7 years
after diagnosis
Cases sig older than
controls
DMSE was effective at
picking up changes in
functioning 1 year before
diagnosis.
(Continued)
J.
E
llio
tt-K
in
g
et
a
l.
/
A
lzh
eim
er’s
&
D
em
en
tia
:
D
ia
g
n
o
sis,
A
ssessm
en
t
&
D
isea
se
M
o
n
ito
rin
g
4
(2
0
1
6
)
1
2
6
-1
4
8
1
3
1
Table 2
Direct cognitive tests (Continued)
Author (Year)
Country and setting
(clinical or applied) Test name Ability tested Ppts Type of ID Groups Outcome (what was sig?)., Comments
Kay et al.
(2003) [42]
UK—Clinical
Setting
Prudhoe cognitive
functioning
test (PCFT)
Overall mental
status,
including:
orientation, recall,
language, praxis,
and calculation.
87 ppts
Aged:
201 years
Down
syndrome
No dementia cases
participated, the
sample was made
up of individuals
with DS only.
PCRT sig. correlated with
Adaptive Behaviour Scale
(ABS—[43]) given to
carers.
PCRT sig. correlated with
degree of ID
More subjects with high levels
(i.e., profound to
untestable) of ID obtained
very low or zero scores on
PCFT.
PCFT 5 reliable
quantitative measure of
cognitive function in DS.
Floor effects suggest that
PCRT is limited to
detecting cognitive
decline to those who are
less disabled.
Devenny et al.
(2002) [44]
United States—
Applied Setting
(Quiet rooms
in ppts’ day
program or at
their residence)
Cued Recall Test
(CRT) [45,46]
Cued memory recall 160 ppts Down
syndrome
Cases 5 with DS
and early
stage DAT
Controls 5 DS
with no DAT
Controls 2 5 ID
no DS and
no DAT
Cut-off value 23 on the
TS 5 sensitivity: 94.7%,
specificity: 93.9%, positive
predictive value: 81.9%
when cases compared to
controls 2.
Usefulness of CRT needs to
be confirmed with
longitudinal data.
Memory declines can occur
several years before DAT
identification.
Tyrrell et al.
(2001) [47]
Ireland—
Potentially a
clinical setting
but not clearly
stated.
Downs Syndrome
Mental Status
Exam (DMSE) [41]
Overall mental status. 285 ppts
Aged: 35–74
mean age
6SD 5 46.5
6 8.2 years
Down
Syndrome
Cases 5 DS with
dementia
Controls 5 DS
without
dementia
Sig different Median scores in
Cases vs Controls for
DMSE.
Test for Severe
Impairment
(TSI) [29]
Mental Status as a
whole, including
immediate
memory recall
and delayed recall.
Sig different Median scores in
Cases vs Controls for TSI.
No floor or ceiling effects in
individuals with
moderate and severe ID.
Deb et al.
(1999) [48]
UK—Setting not
clearly stated.
The Mini Mental
Status Exam
(MMSE) [49]
Overall mental
status
62 ppts
Aged:
351 years
Down
syndrome
Cases 5 DS with
Dementia
(n 5 26)
Controls 5 DS
without
dementia
(n 5 36)
MMSE could only be
completed by 34 (55%)
ppts with DS.
30 ppts got MMSE score less
than 24 (the usual cut-off
for the diagnosis of
possible dementia),
23 ppts (77%; of the 30) did
not have a diagnosis of
dementia.
MMSE not able to be
administered to all ppts
with DS.
And did not accurately
identify cases or controls.
Hon et al.
(1999) [50]
UK—Applied
Setting (Ppts’
home or
day center)
Cambridge Cognitive
Examination
(CAMCOG)
Overall cognitive
functioning
74 ppts
Aged:
301 years
Down
syndrome
1 5 Younger DS
2 5 Older DS
CAMCOG scores 5 well
distributed.
8 ppts (11%) scored 0.
1 . 2 (sig) on total
CAMCOG score
1 . 2 (sig) on 6 out of 7
subscales.
CAMCOG useful unless ID
is severe. May need some
modifications to make it
more accessible.
Better than MMSE as well.
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they are previously familiar or comfortable with; however,
this has resulted in disparity in the instruments being used
across clinical settings. By reaching a consensus, benefits
will not only be seen in assessment efficiency and communica-
tion between health professionals but also in treatment. Earlier
treatment has been suggested to maintain the highest possible
level of cognitive functioning, whereas dementia is mild [114].
Many studies agreed that memory impairment is crucial
to dementia diagnosis and therefore included assessments
of various aspects of memory in their recommendations of
instruments. Some studies chose to assess other cognitive do-
mains either in conjunction with memory assessments or
instead of, for example, tests of orientation, language, intel-
ligence, executive functioning, to name a few. Although the
study by Crayton et al. [97] observed a similar clinical pro-
gression in the participants with ID and dementia that is often
seen in individuals with dementia but no pre-existing ID, the
numerous different cognitive domains tested in the included
studies highlight how onset, course, and progression of de-
mentia can notably differ from person to person.
With this in mind, it is vital to consider the level of intel-
lectual disability that the instrument will be most suitable for
assessing. It is important to also note that instruments often
differ in their applicability to clinical or applied settings. All
instruments discussed can be administered in both settings;
however, some instruments are better suited to one setting
or the other. In any case, level of distraction, how comfort-
able the participant is, length of the test, and accuracy of in-
formation gathered always need to be considered when
deciding where to administer various instruments.4.2. Direct cognitive tests
Evaluation of the direct cognitive tests showed many in-
struments that are appropriate for application with people
who have ID. Studies assessed a variety of levels of ID, DS
only, as well as comparing participants with DS to individuals
with equivalent level of ID but no DS. Therefore, the instru-
ments assessed present a range of levels of ID and could be
applicable across the population, if administered correctly.
Multiple studies indicated good clinical utility for the De-
mentia Rating Scale (DRS [26]) and the Downs Syndrome
Mental Status Exam (DMSE [41]). Furthermore, the study
byMcCarron et al. [40] commented that theDMSEwas partic-
ularly useful in detecting cognitive changes 1 year before de-
mentia diagnosis and therefore could prove useful in early
detection. Studies looking at the DRS only included a total
of 147 participants [25,36], whereas studies looking at the
DMSE included 362 participants [40,47]. Therefore, to
further support the findings of these studies, more research
will need to be completed using the DRS, particularly in a
larger sample size. No studies evaluated showed the DRS or
the DMSE to be unsuitable for dementia diagnostics in ID.
Both instruments were used in applied and clinical settings
in the reported studies, indicating their flexibility in
Table 3
Instruments based on informant reports
Author (Year)
Country and setting
(clinical or applied) Test name Ability tested Ppts and age Type of ID Groups Outcome (wh was sig?) ., Comments
Zeilinger et al.
(2015) [58]
United States—
applied (in large
residential
care homes)
The National Task Group—
early detection screen
for dementia [59]
Dementia
Status
221 carers ID. All
participants
are cared for.
Groups Four feasibili dimensions of use
of the NTG EDSD were
reported o y carers. However,
data from NTG-EDSD were
not assesse directly.
All feasibility imensions were
rated good very good and
80% of the arers found the
NTG-EDS useful or very
useful in th early detection of
dementia.
Reliability and validity of the
instrument for clinical use
in aiding dementia
diagnostic assessment was
not assessed. Therefore,
further research is needed
before use of this
instrument.
Lin et al.
(2014) [55]
Taiwan—Setting
is not clearly
stated but
potentially an
applied setting.
Dementia Screening
Questionnaire for
Individuals with
Intellectual
Disabilities
(DSQIID [60])
Dementia
status
459 ppts
Aged: 451
years
ID of varying
degree
Cases 5 Dementia
Controls 5
Nondementia
Was used to i ntify cases and
controls in is study.
16.3% of ppt n this study were
identified a being demented
based on t DSQIID.
Although originally designed
for use in DS is an effective
tool for diagnosing
dementia in ID.
Activities of Daily
living Questionnaire
(ADL [54])
Daily
functioning
Disability lev and comorbidity
can explai 0% of the ADL
score varia n.
Dementia con itions can only
explain 3% f the ADL score
variation i he study.
ADL would not be an
effective tool for
diagnosing dementia in ID
de Vreese et al.
(2011) [61]
Italy—Applied
setting
Assessment for adults
with Developmental
Disabilities Scale
(AADS-I [61])
Behavior 63 ppts All ID included Good reliabil and validity found. Useful for detecting dementia
if used longitudinally.
Kirk et al.
(2006) [62]
UK—Setting is
not clearly
stated.
Dementia questionnaire
for mentally retarded
people (DMR) [56]
Dementia
status
Behavior
88 ppts
Aged: 401
Varying ID
(n 5 76)
And DS (n 5 12)
All ppts completed
both tests
DMR signific tly related to ABS Would need to use both to
assess an individual for
dementia diagnosis as
neither covers the full
range of factors effected by
dementia.
The Adaptive Behaviour
Scale (ABS-RC2) [43]
ABS significa tly related to DMR 2 questionnaires showed
significant relationships.
Shultz et al.
(2004) [30]
United States—
Applied setting
(rooms at group
homes or
workshops)
The Dementia Scale for
Down Syndrome
(DSDS)
Dementia
status
38 ppts
Aged: 45–74
ID without DS
(32%) and ID
with DS (68%)
Cases 5 Dementia
Controls 5 Non
dementia
Both dementi scales
discrimina d between groups.
All informant reports used
were able to detect cases
vs controls and therefore
could be informative to
clinicians looking to
make a decision
regarding dementia
diagnostics for people
with ID.
Dementia questionnaire
for mentally retarded
people (DMR) [56]
Dementia
status
The dementia cales were not
related to morbid IQ, age,
or sex.
Reiss screen for
maladaptive
behavior [63]
Adaptive
behaviour
Various Reiss reen subscales also
discrimina d between groups.
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Prasher et al.
(2004) [64]
UK—Setting is
not clearly
stated.
Adaptive Behaviour
Dementia Questionnaire
(ABDQ [64])
Behavior 150 ppts
(83 male
67 females)
Mean age:
44 years
Down syndrome Cases 5 Diagnosed
DAT during 5
year study
Controls 5
remained non
dementia
throughout.
The scale has good reliability and
validity.
Overall accuracy 5 92%.
First tool designed
specifically
for detecting DAT
in DS.
Lin et al.
(2014) [65]
Taiwan—Setting
is not clearly
stated but
potentially an
applied setting.
Dementia Screening
Questionnaire for
Individuals with
Intellectual
Disabilities
(DSQIID—[60])
Dementia
Status
196 ppts
Aged:
15–48 years
Down syndrome Younger 5
adolescent ppt
Older 5 adult
ppts
Older . younger on DSQIID
scores.
Older age (P5 .001) and comorbid
conditions (P 5 .003) were
significantly associated with
DSQIID scores.
Age (P , .01), severe disability
level (P , .05), and comorbid
condition (P, .01) significantly
explained 13% of variation in
DSQIID scores after adjusting
for sex, education level, and
multiple disabilities.
DSQIID used well to diagnose
dementia here in DS but
need to consider other
demographic factors that
play a large influence on
dementia status.
Ball et al.
(2004) [66]
UK—Setting is not
clearly stated.
Modified version of
Cambridge
examination for
mental disorders
of the elderly
(CAMDEX)
General
cognitive
functioning
74 ppts at first
visit and 56
ppts at repeat
6 years later
Aged: 301
years
Down syndrome CAMDEX-based diagnosis of AD
shown to be consistent with
objectively observed cognitive
decline (good concurrent
validity) and to be a good
predictor of future diagnosis.
Inter-rater reliability was good
with Kappa .0.8 for 91% of
items and .0.6 for all items.
Modified CAMDEX
informant interview useful
when diagnosing dementia
in ID and DS.
McCarron et al.
(2014) [40]
Ireland & United
States—Clinical
Setting (Memory
clinic)
Daily Living Skills
Questionnaire
(DLSQ) [67]
Daily
Functioning
77 ppts
Aged: 351
years
Down syndrome Cases 5 dementia
Controls 5 non
dementia
Over 14 year follow-up average
age of diagnosis 5 55.41 years
(SD 5 7.14).
Median survival of 7 years after
diagnosis.
Cases older than controls (sig)
Decline in DLSQ score was shown
3-4 years prior to diagnosis.
Presence of dementia also
associated with epilepsy and
sensory impairments.
Changes in DLSQ indicated
diagnosis 3–4 years apriori.
More effective than direct
tests used (DMSE and TSI)
Also informative about
variables that are
associated with dementia
diagnosis.
Dementia Questionnaire
for Mentally retarded
people (DMR) [56]
Among instruments used DMR
most sensitive to tracking
change in symptoms over time
before diagnosis, reporting
changes 5 years prior to
diagnosis. Direct tests used only
reported changes 1 year prior to
diagnosis.
DMR most effective at
reporting changes in
functioning.
(Continued)
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Table 3
Instruments based on informant reports (Continued)
Author (Year)
Country and setting
(clinical or applied) Test name Ability tested Ppts and age Type of ID Groups Outcome (what was sig?) ., Comments
Deb
(2007) [60]
UK—Setting is not
clearly stated.
Dementia Screening
Questionnaire for
Individuals with
Intellectual
Disabilities
(DSQIID—[60])
Dementia
Status
193 ppts
Aged: 23–77
years
Mean age 5
55 years
Down
syndrome
Sensitivity 5 0.92 and
specificity 5 0.97
On DSQIID score of 20.
Internal consistency (a1/4 0.91)
for all its 53 items, and good
test–retest and inter-rater
reliability.
Good construct validity was
established by dividing the
items into 4 factors.
Valid and reliable
screening method
for dementia in DS.
Kay
(2003) [42]
UK—Clinical
setting
Adaptive Behaviour
Scale (ABS)
Behavior 87 ppts
Aged: 201
years
Down
syndrome
No dementia
cases participated,
the sample was
made up of
individuals with
DS only.
Significantly correlated with direct
test Prudhoe cognitive
functioning test (PCFT—see
Table 1)
ABS correlated significantly with
the degree of ID.
Was able to obtain scores for
all levels of ID including
profound, whereas the
direct test was not able to.
Deb et al.
(1999) [48]
UK—Setting is not
clearly stated.
Dementia Questionnaire
for persons with
Mentally Retardation
(DMR) [56]
Dementia
Status
62 ppts
Aged: 351
with DS.
Down
syndrome
Cases 5 Dementia
(n 5 26)
Controls 5 non
dementia (n 5 36)
DMR and DSDS showed good
positive correlation.
A similar positive correlation
was found between the overall
DSDS score and the scores in
the main subcategories of
the DMR.
Direct test used (MMSE)
could not be completed by
all ppts.
Informant scales, rather
than the direct tests,
were more useful for
the diagnosis of dementia
in people with an
intellectual disability.
Dementia Scale for
Down Syndrome
(DSDS [68])
Dementia
Status
Abbreviations: ID, intellectual disabilities; DS, Down syndrome; DAT, dementia Alzheimer’s type; ppts, participants.
NOTE. Tests highlighted in bold indicate repeated use within studies. Age is denoted in years.
J.
E
llio
tt-K
in
g
et
a
l.
/
A
lzh
eim
er’s
&
D
em
en
tia
:
D
ia
g
n
o
sis,
A
ssessm
en
t
&
D
isea
se
M
o
n
ito
rin
g
4
(2
0
1
6
)
1
2
6
-1
4
8
1
3
6
Table 4
Test batteries
Author
Battery name—
designed for.
Informant reports
contained in battery Ability tested
Direct tests contained in
battery Ability tested
Ppts, age, and
group Type of ID
Outcome and
comments
Burt et al. (2000)
[69]—United
States
Working Groups
Battery—designed
for dementia
diagnosis in ID.
- DMR [56]
- The Dementia
Scale for Downs
Syndrome
(DSDS—[68])
- Reiss Screen for
maladaptive
behavior [63]
- Scales of Inde-
pendent Behav-
iour—revised
(SIB-R) [74]
- AAMR Adaptive
Behaviour Scale:
Residential and
Community [43]
- Stress Index
- Dementia status
- Dementia status
- Emotional/moti-
vational changes
- Behavior
- Behavior
- Differential di-
agnostics
(stress)
- Test for Severe Impair-
ment modified (TSI
[29,70])
- Stanford Binet senten-
ces [71]
- Flud modified [72]
- Spatial Recognition
Span [75]
- Autobiographical mem-
ory
- Orientation [77]
- Boston Naming Test
[78]
- McCarthy Verbal
Fluency [79]
- Simple commands
(modified from Haxby
[41])
- Purdue Pegboard modi-
fied [80]
- Developmental Test of
Visual Motor Integra-
tion [81]
- Memory and
Other Cognitive
decline
- Immediate
recall
- Immediate and
delayed recall
- Immediate
spatial recogni-
tion
- Autobiograph-
ical memory
- Orientation to
time and place
- Expressive vo-
cabulary
- Language
fluency
- Receptive lan-
guage
- Fine motor
speed
- Perceptual mo-
tor skills
None reported in first study – reli-
ability studies did follow.
- Pyo et al. [28] showed good
reliability on the
Autobiographical memory and
Orientation tests.
- Pyo et al. [73] only looks at
orientation and shows significant
differences between DAT group
and controls but Orientation tests
alone are not reliable for
diagnosis.
- Pyo et al. [76] showed
autobiographical memory tests
to be reliable.
1–1.5 hours to
administer.
Longitudinal
administration is
crucial to observing
clinical change.
(Continued)
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Table 4
Test batteries (Continued)
Author
Battery name—
designed for.
Informant reports
contained in battery Ability tested
Direct tests contained in
battery Ability tested
Ppts, age, and
group Type of ID
Outcome and
comments
Palmer (2006)
[82] - USA
Not given—designed
for dementia
assessment in
individuals with
Mental
Retardation.
- The early signs of
dementia check-
list [83]
- Dementia status - The Color Trials Test
[84]
- The Boston Naming
Test [78]
- The Controlled Oral
Word Association Test
(COWAT—Spreen et al.
[85])
- The Fuld Object Mem-
ory Evaluation [86]
- Visual Attention
and Concentra-
tion
- Expressive Vo-
cabulary
(Agnosia)
- Language: sem-
atic fluency
- Memory and
Learning
22 ppts
Aged: 33–66
years
Groups:
Cases 5
Dementia
Controls 5
matched for IQ,
age, presence of
DS and sex but
no dementia
present.
Mild or Moderate
ID.
2–2.5 hours to
administer.
Cases , Controls
in all areas
assessed.
Van der Wardt et
al. (2011)
[87]—UK,
applied
setting
Cognitive
computerized test
battery for
individual’s with
intellectual
disabilities
(CCIID)—
designed to assess
IQ in individuals
with ID.
N/A N/A - Corsi Block Tapping
Test [88]
- Series
- Odd one out
- Jigsaw
- Visual/spatial
working mem-
ory
- Inductive
Reasoning
- Inductive
Reasoning
- Visual/Spatial
Abilities
Reliability and
validity studies
were conducted
in various ID
populations and
showed the
CCIID to be a
valid and
reliable
instrument for
testing IQ.
ID all levels 30 minutes to
administer.
Originally designed
as an IQ test for
verifying eligibility
for Paralympic
sporting events, but
has been suggested
for use in dementia
assessment – not
yet tested however
for this purpose.
Silverman et al.
(2004) [89]—
United States,
applied
setting (ppts’
residence or
day program
facility)
- Informant inter-
views conducted
based on a clinical
record review of
the participants
medical history.
- The Dementia
Questionnaire for
Mentally Retarded
persons [56].
- Medical history
- Cognitive abili-
ties and social
skills
- IBR evaluation of
mental status [90]
- Downs syndrome
Mental Status Exami-
nation [41]—including
expanded memory
section.
- Orientation
- Overall Cogni-
tive Functioning
- Overall cogni-
tive functioning
273 ppts
Aged: 451
years
After testing
grouped into:
1) Not
demented
2) Question-
able
3) Possible
dementia
All levels of ID. 2 hours to administer.
18 month
longitudinal
analysis presented.
Findings suggest
that by conducting
a full assessment of
cognitive abilities
like presented here,
diagnosis of
dementia can be
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- Part 1 of the
American Associ-
ation on Mental
Deficiency Adap-
tive Behaviour
Scale (ABS [91])
- Reiss Screen for
Maladaptive
Behaviour [63]
- Description of
functional abili-
ties
- Screening for
possible depres-
sion, psychosis,
and behavior
problems.
- Test of severe impair-
ment (TSI—Albert et al.
[29])
- The Peabody Picture
Vocabulary Test –
Revised (PPVT—Dunn
et al. [37])
- Verbal Fluency Test
[79]
- The Beery Visual Motor
Integration Test, long
form [92]
- Block design subtest of
WISC-R [93]
- Selective Reminding
Test [34]
- Receptive vo-
cabulary
- Verbal fluency
- Construction
abilities
- Visual spatial
memory
- Episodic mem-
ory
4) Definite
dementia
5) Declines
with com-
plications
made a lot more
rapid and accurate.
Das et al. (1995)
[36]—United
States and
Canada,
applied
setting (quiet
rooms in
workshops,
group or
independent
living setting)
Das Naglieri
Cognitive
Assesment
System—designed
to assess cognitive
decline due to
aging among
individuals with
Downs Syndrome.
N/A N/A - Planned search [94]
- Matching numbers [95]
- Number finding [96]
- Expressive Attention
[96]
- Receptive Attention
[95]
- Simultaneous Verbal
- Figure Memory
- Word Series
- Color ordering
- Speech rate
- Visual search
and planning
- Planning
- Attention, Vigi-
lance
- Expressive
attention
- Receptive
Attention
- Language
- Simultaneous
processing
memory
- Recall Memory
- Spatial Memory
- Speech rate
(Verbal
Fluency)
63 ppts
Aged: 50–62
Groups
1) Young DS
(n 5 16)
2) Old DS (n
5 16)
3) Young
Non-DS (n
5 16)
4) Old Non-
DS (n 5
15)
ID with DS or ID
without DS
with equivalent
level of ID.
1.5–4 hours to
administer – a lot
of variation in time
taken.
2 , than all other
groups on all tasks.
Seen most on tasks
requiring planning
and attention.
(Continued)
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Table 4
Test batteries (Continued)
Author
Battery name—
designed for.
Informant reports
contained in battery Ability tested
Direct tests contained in
battery Ability tested
Ppts, age, and
group Type of ID
Outcome and
comments
Crayton et al.
(1997)
[97]—UK
Neuropsychological
Assesment of
dementia in
adults with
intellectual
disability—
designed for
dementia
assessment in
Downs
syndrome.
Cognitive test battery
was compared to.
- Vineland Adap-
tive Behaviour
Scale (VABS—
Sparrow et al.
[98])
- Adaptive behav-
iour
- British Picture Vocabu-
lary Scale (BPVS—
Dunn, Dunn, Whetton
& Pentilie, 1982) [99]
- Orientation (taken from
Cambridge Mental Dis-
orders of the Elderly
Examination—CAM-
DEX [100]:
- Picture Naming (taken
from BPVS)
- Picture identification
(taken from BPVS)
- Acting on request
- Card Sorting task
Computerized tests
- Visual memory
- Pattern recognition
- Spatial recognition
- Matching-to-sample
- Delayed response
- Conditioned associative
learning
- Receptive Lan-
guage
- Orientation
- Aphasia
- Agnosia
- Receptive Lan-
guage
- Executive Func-
tions
- Visual Memory
- Recognition
- Spatial Abilities
- Object recogni-
tion
- Delayed
response
- Conditioned
associative
learning
70 ppts
Aged: 281
Mean Age: 42.8
Groups
1) under 40
years old
2) between 40
and 49
years 11
months old
3) aged 3 501
years
DS 1.5 hours to
administer.
VABS and all
neuropsychological
tests negatively
correlated (sig) –
preexisting global
cog impairment
shown on these
tests
No difference
between age groups
(1, 2, and 3) on
neuropsychological
deficits. – because
of screening
method used before
study.
2 & 3 , 1
performance on
memory tests (sig)
Results suggest
sensitive tests that
were used could be
useful in dementia
diagnostic process.
Oliver et al.
(1998) [101]
– UK
Different test batteries
were collated,
including the
CANTAB and
CAMCOG, plus
extra tests added for
the purpose of this
study. (Please see
across) – designed
to detect age-
related cognitive
change in DS.
- Vineland Adap-
tive Behaviour
Scale (VABS [98])
- Adaptive behav-
iour
- Visual memory battery
(part of Cambridge
Neuropsychological
Automated Test Bat-
tery—CANTAB, see
[103]), only 2 sections
analyzed in this study,
delayed response and
conditioned associative
learning tasks.
- Orientation section of
CAMCOG (part of the
Cambridge Assessment
for Mental Disorder in
the Elderly—CAM-
DEX)
Asked to name 14 pictures
of everyday objects and
- Learning and
memory
- Aphasia and
Agnosia
57 ppts
Aged: 301
Groups
1) No cogni-
tive deteri-
oration
2) Cognitive
deteriora-
tion
3) Moderate
cognitive
deteriora-
tion
4) Severe
cognitive
deteriora-
tion
DS Does not state how
long the battery
took to administer.
28.3% of ppts
showed severe
cognitive
deterioration, like
apraxia or agnosia.
A higher
prevalence of these
impairments was
associated with
older age.
Rate of cognitive
deterioration also [
w/age & degree of
pre-existing
cognitive
impairment.
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identification following a
verbal instruction.
Also asked to carry out
simple actions on a verbal
cue (e.g., clap your
hands).
- The British Picture Vo-
cabulary Scale (BPVS)
(Dunn, Dunn, Whetton
& Pentilie, 1982)
- Extra verbal memory
test added to batteries
used. (adapted from the
Memory for Sentences
Test – [102])
- Extra procedure added
at the start of the mem-
ory for objects test,
involving naming, iden-
tification, immediate
recall and delayed
recall.
- Apraxia
- Receptive lan-
guage
- Verbal memory
- Memory
Deterioration in
memory, learning
and orientation
preceded the
acquisition of
aphasia, agnosia
and apraxia.
Pattern of cognitive
deterioration seen
with individuals
who have DS in this
study is comparable
to the pattern
reported in
individuals who
have Alzheimer’s
disease but do not
have DS.
Jozsvai et al.
(2002)
[104]—UK,
Clinical
Setting
Not given—designed
to assess cognitive
decline in DS.
- The Dementia
Scale for Downs
syndrome (DSDS
[68])
- Dementia status - The Peabody Picture
Vocabulary test revised
(PPVTr – [37])
Battery included:
- Information and Orien-
tation Questions (IO)
- Block Design Test (BD
– from WISC-R: [93])
- Fuld Object Memory
Evaluation (FULD—
[86,105])
- Grocery list (GL)
- Boston Naming Task
(BNT—[78])
- Test of Apraxia (PX)
- Receptive vo-
cabulary, verbal
intelligence
- Orientation
- Visuo-construc-
tional praxis
- Immediate and
delayed memory
- Category
fluency
- Expressive vo-
cabulary
- Apraxia
35 ppts
Aged: 281
years
Groups:
Cases 5
diagnosed DAT
using DSDS (n
5 12)
Controls 5
without DAT (n
5 23)
DS
- Does not
include
more severe
ID in sample
Doesn’t state how
long the battery
took to administer.
FLUD and IO
shown to be most
useful tests in
battery—must be
wary of practice
effects though.
BNT and BD, most
effected by aging &
had least diagnostic
ability.
(Continued)
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Table 4
Test batteries (Continued)
Author
Battery name—
designed for.
Informant reports
contained in battery Ability tested
Direct tests contained in
battery Ability tested
Ppts, age, and
group Type of ID
Outcome and
comments
Johansson et al.
(2002)
[106]—
Sweden
Not given—designed
to assess dementia
in DS.
Informants were interviewed with questions
regarding the ppts abilities in the following
aspects and any changes observed in these
abilities:
1) Change (global changes in ppt)
2) Support
3) Learning Adaptability
- Spatial tests of memory
- Verbal tests of memory including: objects to be
remembered, auditive learning, visual learning,
supported learning, sensing items inside a bag,
Where did I put it?
- Other cognitive tests included:
- Understanding pictures
- Simplified Arithmetic
- Telling the time on a clock
- Ability to estimate time taken
- Understanding of cause and effect
- Drawing ability
- Proper prepositions
- Copying pictures with and without the original
- Agnosia: what did you draw?
- Word Fluency
- Routine Decisions
- Understanding reverse order
- Arranging a coffee break
- Naming (aphasia, agnosia, and apraxia)
- Long-term memory questions included:
- Biographical questions
- Memory of the dys preceding the interview
- Past and present friends and staff at residential
and occupational settings
- Semantic memory
- Prospective memory
9 ppts
Aged: 26–56
Groups:
1) No Decline
2) Possible
Decline
3) Decline
DS Ppt section took 1.5–
2 hours to
administer.
Advocates a
combination of
testing and
interviewing in
order to gain a full
clinical picture.
Witts (1998)
[107]—UK,
applied
setting (adult
training
centers.
Severe Impairment
Battery (SIB
[108])—designed
to assess cognitive
functioning of the
severely demented
client.
- Vineland Adap-
tive Behaviour
Scale (VABS [98])
-Adaptive behavior Battery tests focus on:
- Attention
- Orientation
- Language
- Memory
- Visuo-perception
- Construction
- Praxis
- Social interaction
Carers provide most of the info for the battery.
33 ppts
Mean age 5 36
years
DS 20 minutes to
administer.
Good reliability
and validity found.
No floor effects
encountered.
Should be used
longitudinally.
Abbreviations: ID, intellectual disabilities; DS, Down syndrome; DAT, dementia Alzheimer’s type; [, increases; ppts, participants.
NOTE. Tests highlighted in bold indicate repeated use within studies. Age is denoted in years.
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Records idenﬁed through 
database searching
(n =  9840)
Sc
re
en
in
g
In
cl
ud
ed
El
ig
ib
ili
ty
Id
en
ﬁ
ca
o
n
Records screened: 
Title 
Records excluded
(n = 9766 )
Full-text arcles 
assessed for eligibility
(n = 74 )
Full-text arcles 
excluded, with reasons
(n =  38 )
Studies included in 
qualitave synthesis
(n =  47)
Instruments Extracted
(n =  43 )
Studies idenﬁed 
through hand-search
(n = 11 )
Direct Tests
(n =  33 )
Informant Reports
(n = 10 )
Test Baeries
(n =  10)
Independent Direct Tests
(n =  23 )
Fig. 1. A PRISMA flow diagram detailing the search strategy and results.
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dementia diagnostics.
Additionally, the modified version of the Selective Re-
minding Test (SRT [35]) was shown to have good utility in
early detection, picking up cognitive changes between 1
and 3 years before dementia diagnosis [33]. Although there
were no studies opposing this conclusion, this was only
shown in one study of 155 participants; therefore, further
research is required to support the clinical utility of the SRT.
Discrepancies in the effectiveness of the mini mental sta-
tus examination (MMSE [49]) and the test for severe impair-
ment (TSI [29]) arose. For example, the study by Boada et al.
[53] was able to show the MMSE discriminated effectively
between people with ID and people with ID and dementia.Similarly, Tyrrell et al. [46] replicated findings using the
TSI. However, studies are inconsistent as Deb et al. [48]
found the MMSE to show no significant difference between
people with ID with and without dementia. Pyo et al. [27]
also found no significant difference with the TSI.
The direct cognitive assessments shown to be most effec-
tive in this literature review included the DRS, DMSE, and
SRT; however, each requires further assessment in larger
sample sizes. Several studies noted the importance of tests
being administered longitudinally, as there are no normative
data for individuals with an ID as of yet. If used longitudi-
nally clinicians can observe any cognitive decline, which
could be very informative and necessary for making a deci-
sion regarding dementia diagnosis. Having said that,
Table 5
Other studies reviewed
Author (year) Country Document Summary of key points
Moran et al. (2013) [23] United States Advise
document
- A patient’s history is key.
- Gives a list of cognitive assessments and states that one should be used.
- Regardless of the clinician’s choice of instrument, the focus should be on recognizing change and
decline in relation to a premorbid baseline.
Zelinger et al.
(2013) [24]
Austria Literature
review
- No consensus in the literature and practice about what instrument should be used to diagnose
dementia in ID.
- Establishing consensus would improve the quality of assessment in clinical practice & benefit
research.
Nieuwenhuis-Mark
(2009) [20]
The
Netherlands
Literature
review
- No consensus on how dementia should be diagnosed in Down Syndrome.
- Longitudinal studies using multiple tests accessing cognitive, emotional, motivational and daily
functioning in individuals are recommended as is focus on change in functioning, ‘bounce pat-
terns’ and multidisciplinary diagnosis
Krinksky-McHale
et al. (2013) [109]
United States Literature
review - While the intellectual and developmental disabilities field has for some time recognized the need
to develop best-practices for the diagnosis of MCI and dementia, there remains a pressing need
for empirically based assessment methods and classification.
Nagdee (2011) [110] South Africa Literature
review - In patients with ID, standard clinical methods need to be supplemented by careful, longitudinal
behavioral observations and individually tailored assessment techniques. Co-morbidity, multiple
biological, psychological, and socio-environmental factors, and complex interactions among
events, are the reality for many aging people with ID. Determining the various influences is often
a formidable clinical task but should be systematically carried out using medical, cognitive,
behavioral, neuropsychiatric, and psycho-social frameworks.
Strydom et al.
(2003) [111]
UK Literature
review - The most promising informant-rated screening tool in most adults with ID including Down
syndrome (DS) diagnosis is the Dementia Questionnaire for Persons with Mental Retardation
(DMR). However, sensitivity in single assessments is variable, and cut-off scores need further
optimization. In those with DS, the Dementia Scale for Down Syndrome (DSDS) has good
specificity but mediocre sensitivity. The Test for Severe Impairment and Severe Impairment
Battery are two direct assessment tools that show promise as screening instruments but need
further evaluation.
Suh (2013) [112] Hong Kong Advise
document
- Discusses a method for viewing statistical analyses of diagnostic screening tool results.
- Values clinical judgment and advises that we adhere to 2 standard deviations away from popu-
lation norm as cutoffs rather than a set score. As this will reduce false biases and false negatives
and allow common sense to override whether pathology is present there.
J. Elliott-King et al. / Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring 4 (2016) 126-148144Margallo-Lana [115] highlighted findings that longitudinal
follow-up is not useful in people with severe ID. So, test se-
lection needs to be carefully tailored to the level of func-
tioning of the individual and the setting in which the
testing can take place.4.3. Informant reports
Instruments classed as informant reports evaluated
noncognitive concepts, such as activities of daily living
and functioning, as individuals with dementia find many ac-
tivities of daily living difficult due to decline in episodic
memory [116]. Informants are often in a good position to
observe these changes. Furthermore, informants reporting
on everyday functioning, prospectively or retrospectively,
are much more effective than reporting on changes in mem-
ory [117]. These noncognitive concepts have also been
shown to hold greater significance to individuals with ID
and their carers than evaluation of cognitive changes
[118]. Although the effectiveness of informant reports
often varies from study to study (e.g., Jozsvai et al.[119]), in the studies reviewed here, informant reports
were shown overall to be an effective way of aiding in de-
mentia diagnostics. As informant reports are not completed
by the participant, they are exceedingly suitable for individ-
uals who have severe ID. A variety of both clinical and
applied settings were used in the reviewed studies and no
studies commented on the setting being inappropriate for
the assessment, but again level of distraction and accuracy
of data do always need to be considered when deciding
where to administer instruments.
In all the studies that compared informant reports to direct
cognitive tests, informant reports were shown to be more
effective than cognitive assessments [40,42,48]. The Daily
Living Skills Questionnaire (DLSQ [67]) was noted to be
effective in early detection, showing changes indicative of
dementia 3–4 years before diagnosis. The Dementia
Screening Questionnaire for Individuals with Intellectual
Disabilities (DSQIID [60]) was administered to 848 partici-
pants across numerous reviewed studies and each found the
questionnaire to be informative. However, the study by Lin
et al. [55,65] did note that other demographic factors that
J. Elliott-King et al. / Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring 4 (2016) 126-148 145influence dementia status do need to be considered alongside
DSQIID administration.
Results on the Activities of Daily Living Questionnaire
(ADL [54]) were better explained by disability level and co-
morbidity than dementia status, and therefore, this was the
only informant report reviewed to be shown to be unsuitable
for use in dementia diagnostics for people with ID.4.4. Test batteries
Test batteries reviewed contained a variety of instruments
including both direct cognitive tests and informant reports. All
batteries reviewed were effective in discriminating between
ID dementia cases and ID controls, and none described floor
effects, indicating promise for clinical utility. However,
Jozsvai et al. [104] found the Boston Naming Task (BNT
[78]) and the Block Design Test (BD from WISC-R [93])
contained in their test battery to be most affected by aging.
Thus, these two tests were shown to have least diagnostic
utility out of the battery. So, if a practitioner was to select
this test battery, it is advised that these tests be removed.
The Cognitive Computerized Test Battery for Individ-
ual’s with Intellectual Disabilities (CCIID [87]) is yet to
be studied for the purpose of dementia diagnostics in indi-
viduals with ID. However, the CCIID has been validated in
adults with ID. Moving forward, this battery should be as-
sessed in a demented ID sample before clinical utility. Simi-
larly, the Das Naglieri Cognitive Assessment System is yet
to be assessed comparing ID dementia cases to ID controls.
Das et al. [36] assessed cognitive decline as a result of aging
that occurs among adults with DS with this test battery and
showed the battery to be effective at detecting age-related
cognitive decline. However, research has not yet assessed
its utility in discriminating between dementia cases and con-
trols in an ID or DS sample. Therefore, further research
would need to be carried out to determine this battery’s use-
fulness in aiding with dementia diagnosis.
Test batteries assess a range of cognitive abilities without
relying on informants. Consequently, to best inform dementia
diagnostics administering a test battery longitudinally can
highlight any decline and track cognitive functioning in the
years before dementia onset to best aid a clinician in making
a diagnostic decision. Test batteries, however, do have
numerous practical implications that need to be considered.
Many require touch screen laptops, which are costly if the tech-
nology is not already available to the clinician. The laptops
would also need to be near an available plug socket to admin-
ister tests without interruption, which might not be practical in
an applied setting,which limits their potential utility. Paper and
pen forms of certain cognitive tests are available, so if it is not
feasible to have technology then the same concept of assessing
a range of cognitive functions can be applied.
The direct tests and informant reports recommended above
and described in the tables can help in deciding which tests to
administer. However, comparing dementia cases to controls
before clinical utility is advisedwhere limited evidence is avail-able on use for people with ID, which is often the case for
numerous instruments presented throughout this review. Like-
wise, it must be noted that all test batteries presented require
further testing to validate their clinical utility in an appropriate
sample, particularly those with concerns noted above.
4.5. Combining methods
Previous reviews argue that a combination ofmethods can
best inform dementia diagnosis in individuals with ID (e.g.,
Burt et al. [120]). Johansson et al. [106] describe how cogni-
tive testing and informant interviewing could be the most
effective way to combine methods and gain a full clinical
picture. Combining methods for diagnosis, although effec-
tive, may be time consuming, and therefore the combination
of methods chosen need to be carefully considered. This
further supports the recommendation of the use of a test bat-
tery to aid diagnosis, as a number of batteries presented
contain informant reports as well as cognitive assessments.
4.6. Limitations of this review
This review has some limitations. Most notably, instru-
ments that compiled the test batteries were not evaluated
individually as direct cognitive tests. To improve this
research, instruments used within the batteries could be as-
sessed individually as well as part of the battery. However,
owing to the benefits highlighted in this review of test batte-
ries, it was felt that test batteries would be of more benefit to
clinicians to be presented as a whole.
4.7. Conclusion
In summary, it can be recommended that when diag-
nosing dementia in individuals with ID test, batteries can
offer the most informative assessment of cognition. This
could be alongside informant reports or a battery that con-
tains informant reports to provide valuable information on
the daily functioning of the individual as well as an overall
assessment of cognitive functioning. Tables provided high-
light previous validation of test batteries, and before select-
ing a battery clinicians should review literature presented.
Particularly considering the length of the test battery, the
level of ID of the individual being assessed and the setting
in which the instrument will be administered. It may be
advised to complete a shorter instrument when the ID is
more severe. In this case, the CCIID or the SIB each takes
30 minutes or less to administer. Nonetheless, breaks should
be offered to participants throughout testing, and it is always
possible to split testing sessions into multiple shorter ses-
sions.
Completing a test battery that covers both informant re-
ports of daily functioning and assesses a full range of cogni-
tive abilities is advised. This can enable clinicians to gain a
more in-depth account of a participant’s functioning and
symptoms, hence can best inform a decision regarding de-
mentia diagnosis.
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1. Systematic review: A systematic literature search
was conducted in four databases (PubMed, Science
Direct, Google Scholar, and PsycInfo). Studies
were identified and selected using predefined inclu-
sion and exclusion criteria; coded and classified ac-
cording to assessment type by two independent
researchers, with a third consulted when discrep-
ancies arose.
2. Interpretation: The review collates diagnostic instru-
ments and presents strengths and weaknesses of each
type of assessment and each individual test. Findings
indicated that test batteries to offer the most practical
and efficient method of assessment. The variation in
areas of functioning affected by dementia in individ-
uals’ with ID can be assessed with a battery to best
inform a clinician’s decision.
3. Future directions: The review proposes specific test
batteries that could be most beneficial; however,
small sample sizes in cited studies suggest that
further studies need to investigate the use of these
batteries in larger samples of individuals with ID to
better highlight diagnostic potential for each test.References
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